Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis

University of Copenhagen Rigshospitalet, Copenhagen

Columbia University Medical Center, New York

Mount Sinai Beth Israel, New York

Charite - Campus Virchow-Klinikum, Berlin

New York Medical College, Valhalla

Children's Hospital of Pittsburgh of UPMC, Pittsburgh

Children's Hospital of Philadelphia, Philadelphia

Virginia Commonwealth University, Richmond

Duke University Health System, Durham

Medical University of South Carolina, Charleston

University of Florida College of Medicine, Gainesville

Central Florida Pulmonary Group, Altamonte Springs

University of Miami Health System, Miami

University of Alabama at Birmingham, Birmingham

Nationwide Children's Hospital, Columbus

Toledo Children's Hospital, Toledo

Akron Children's Hospital, Akron

University of Michigan Health System, Ann Arbor

University of Iowa, Iowa City

Northwestern University Memorial Hospital, Chicago

OSF Saint Francis Medical Center, Peoria

Children's Mercy Kansas City, Kansas City

University of Nebraska Medical Center, Omaha

Santiago Reyes, M.D. P.C., Oklahoma City

University of Texas Health Science Center at Tyler, Tyler

ICON Early Phase Services, San Antonio

National Jewish Health, Denver

St. Luke's CF Center of Idaho, Boise

University of Utah, Salt Lake City

Children's Lung Specialists, Las Vegas

Stanford University Medical Center, Stanford

Providence Alaska Medical Center, Anchorage

Maine Medical Center, Portland

Massachusetts General Hospital, Boston

Boston Children's Hospital, Boston

St. Paul's Hospital, Vancouver

Institut Universitaire de Cardiologie et de Pneumologie de Quebec, Québec

Stockholm CF Center, Stockholm